ArticleFrontiers in endocrinology2026

Optimal timing of recombinant growth hormone therapy in Prader-Willi syndrome: the case for very early initiation.

Hussain Alsaffar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.